article

Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution

European Journal of Cancer · 1996 · Vol. 32(7) · pp. 1135–1141

G Buccheri✉(Tumour Institute of Tuscany)Domenico Ferrigno(Tumour Institute of Tuscany)Marcello Tamburini(Tumour Institute of Tuscany)

View via DOI Publisher page

Lung Cancer Treatments and Mutations Lymphoma Diagnosis and Treatment Lung Cancer Research StudiesMedicinePerformance statusKarnofsky Performance StatusLung cancerInternal medicineUnivariateUnivariate analysisMultivariate analysisPathologicalOncology

MeSH terms

AdultAgedAged, 80 and overFemaleHumansLongitudinal StudiesLung NeoplasmsMaleMiddle AgedPredictive Value of TestsPrognosisProspective StudiesSeverity of Illness IndexSurvival RateKarnofsky Performance Status

Citations

624

FWCI

2.22

field-weighted impact

References

Percentile

88%

vs. same field & year

Citations per year

Cited by

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine